Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

ConferenceMedicine and clinical research · Berlin, Germany

EULAR 2027 European Congress of Rheumatology

EULAR 2027, the European Congress of Rheumatology organised by the European Alliance of Associations for Rheumatology, takes place in Berlin, Germany, from 9 to 12 June 2027 and invites regular abstracts and case reports on clinical and basic research in rheumatic and musculoskeletal diseases. This guide covers topic areas consistent with the congress scope, readiness checks, what abstract reviewers typically value and practical steps for submitting before the 15 January 2027 abstract deadline.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
15 January 2027
Last checked
10 November 2026
Organiser
European Alliance of Associations for Rheumatology (EULAR)
Sources
1
Submit an abstract

Key dates

Abstract deadline
15 January 2027
Full paper deadline
Abstracts only, or not stated
Conference dates
9 June 2027 – 12 June 2027
Details last checked
10 November 2026
Submit an abstract

About the conference

Conference
EULAR 2027 European Congress of Rheumatology
Organiser
European Alliance of Associations for Rheumatology (EULAR)
Venue
Berlin, Germany
Scope
Annual European congress for clinical and basic research on rheumatic and musculoskeletal diseases, with regular abstracts and case reports invited.
Submission types
Abstracts; confirm formats and word limits on the official page

Topics consistent with the programme

  • Clinical studies of inflammatory arthritis, including rheumatoid and psoriatic arthritis
  • Research on systemic autoimmune diseases such as lupus and systemic sclerosis
  • Basic and translational studies of immune mechanisms in musculoskeletal disease
  • Osteoarthritis, osteoporosis and other degenerative or metabolic bone conditions
  • Epidemiology, outcomes and health services research in rheumatology
  • Case reports describing unusual presentations or treatment responses

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you submit

  1. Confirm that the work concerns rheumatic or musculoskeletal diseases, in clinical or basic research.
  2. Decide whether the submission is a regular abstract or a case report and follow the matching format.
  3. Ensure the results are available and summarised with clear methods and conclusions.
  4. Check the abstract category, word limit and disclosure rules on the official abstract information page.
  5. Prepare a complete, co-author-approved abstract before 15 January 2027.

Why This Conference Matters

Rheumatic and musculoskeletal diseases affect people across the life course and involve clinicians, laboratory scientists, allied health professionals and patient organisations. The EULAR congress brings these groups together each year, so presenting there places new findings in front of the European and international rheumatology community at once. For early-career researchers, an accepted abstract offers visibility, feedback from experienced colleagues and a route to collaboration, while for established groups it is an opportunity to share emerging clinical and mechanistic results ahead of full publication.

Who Should Submit

Academic backgrounds

  • Rheumatology
  • Immunology
  • Musculoskeletal and bone research
  • Clinical epidemiology
  • Physiotherapy and allied health

Institutions and sectors

  • University hospitals and rheumatology departments
  • Academic research institutes
  • Pharmaceutical and biotechnology companies
  • Patient and health professional associations

What Reviewers Typically Value

  1. Clinical findings that could inform diagnosis, monitoring or treatment decisions in rheumatology.
  2. Mechanistic studies that clarify disease pathways and point to potential therapeutic targets.
  3. Well-characterised cohorts or registries that report outcomes with appropriate statistical analysis.
  4. Case reports that describe a genuinely unusual presentation and draw a clear clinical lesson.

Ideas You Could Develop

Treat-to-target outcomes in a local cohortAn analysis of disease activity and remission rates in an inflammatory arthritis cohort managed with a treat-to-target strategy.
Biomarkers of flare in lupusA study examining whether selected laboratory markers predict disease flares in patients with systemic lupus erythematosus.
Rare presentation case reportA case report describing an atypical musculoskeletal presentation of a systemic disease and the diagnostic reasoning that followed.

Your Plan to the Deadline

A suggested schedule working back from 15 January 2027. Adjust it to the stage your work has reached.

  1. By 4 Dec 2026

    Open the official call for abstracts; confirm the tracks, word limit, format and author rules.

  2. By 18 Dec 2026

    Agree the key result, the authors and the presenting author.

  3. By 1 Jan 2027

    Draft the structured abstract to the word limit, with results stated as numbers.

  4. By 8 Jan 2027

    Circulate to co-authors and an independent reader; revise.

  5. By 13 Jan 2027

    Final checks: title, author affiliations, conflicts of interest and track selection.

  6. By 15 Jan 2027

    Submit through the official abstract system before the deadline.

What you gain

  • Feedback from peers working on the same questions.
  • A citable abstract or proceedings paper.
  • Contacts for collaboration, employment and future funding.
  • A step towards a full journal article.

What happens after you submit

  1. Acknowledgement: the abstract system confirms receipt; keep the submission number.
  2. Review: the scientific committee scores abstracts against the track criteria.
  3. Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
  4. Registration: presenting authors usually must register by a stated date.
  5. Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.

What the Organisers Are Looking For

The congress seeks clinical and basic research on rheumatic and musculoskeletal diseases, presented as regular abstracts or case reports. Strong submissions typically state a clear question, report results rather than plans, and explain the relevance for patients or for understanding disease. Categories, formatting rules and presentation formats should be confirmed on the official EULAR abstract information page before submission.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

FAQs

Questions Researchers Ask

The next published deadline is 15 January 2027. Dates can change, so confirm them on the official page before you plan your work.

The congress scope indicates that case reports are invited alongside regular abstracts, so a well-documented case may be suitable. Specific requirements for case reports may differ from those for research abstracts, so check the EULAR abstract information page before submitting.

The official page lists abstract submission; check it for any full paper or proceedings option.

Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.

Sources

  1. European Alliance of Associations for Rheumatology (EULAR). (2026). EULAR 2027 European Congress of Rheumatology. Retrieved 10 November 2026, from https://congress.eular.org/abstractgeneralinfo

How to cite this page

Pubrica Insights. (2026). EULAR 2027 European Congress of Rheumatology. Pubrica. https://pubrica.com/insights/calls-and-conferences/eular-2027-european-congress-of-rheumatology/

EULAR 2027Next deadline 15 January 2027

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.